ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
Renal Insufficiency
IGA Glomerulonephritis
Renal Cell Carcinoma
Carcinoma

Kidney Disease trials near Austin, TX, USA:

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Enrolling
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 338 other locations

(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Phase 3

Novo Nordisk
Novo Nordisk

San Marcos, Texas, United States and 944 other locations

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Dapagliflozin in combination with placebo

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 581 other locations

This study is to evaluate the efficacy and safety of PLS240 in patients with hemodialysis-dependent end stage kidney disease (ESKD)...

Enrolling
End-stage Kidney Disease (ESKD)
Secondary Hyperparathyroidism
Drug: PLS240
Drug: Open-Label Extension PLS240

Phase 3

Pathalys Pharma

Austin, Texas, United States and 67 other locations

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a...

Enrolling
Chronic Kidney Diseases
End Stage Renal Disease
Device: SelfWrap Bioabsorbable Perivascular Wrap
Procedure: Untreated AVF Control
VenoStent

Austin, Texas, United States of America and 9 other locations

of KBP-5074 in adult participants who have stage 3b/4 chronic kidney disease (CKD) (estimated glomerular filtration rate \[eGFR\] c ...

Active, not recruiting
Chronic Kidney Diseases
Drug: KBP-5074
Drug: Placebo

Phase 3

KBP Biosciences

Austin, Texas, United States and 215 other locations

of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...

Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Austin, Texas, United States and 707 other locations

The objective of this study is to establish that the MB-102 transdermal fluorescence-measured Glomerular Filtration Rate (GFR) using the MediBeacon®...

Active, not recruiting
Kidney Failure
Kidney Diseases
Device: MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)
Drug: MB-102

Phase 3

MediBeacon

Austin, Texas, United States of America and 4 other locations

Locations recently updated

The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and hypertension not a...

Enrolling
Hypertension
High Cardiovascular Risk
Drug: Placebo
Drug: Zilebesiran

Phase 2

Alnylam Pharmaceuticals
Alnylam Pharmaceuticals

Austin, Texas, United States and 140 other locations

or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Austin, Texas, United States and 539 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems